“MULTIMODALITY TREATMENT OF GLIOBLASTOMA PATIENTS USING DIFFERENT TEMOZOLOMIDE REGIMENS IN POSTOPERATIVE CHEMORADIOTHERAPY”. Voprosy Onkologii, vol. 63, no. 6, June 2017, pp. 915-9, https://doi.org/10.37469/0507-3758-2017-63-6-915-919.